OncoScanner.com is a pioneering startup that focuses on intraoperative recognition of collected tissues during surgical procedures to remove breast cancer. The company's innovative solution, the oncological probe, has been clinically examined on several hundred patients, with a research demonstrating its ability to ensure the correct identification of cancer tissues. Notably, the sensitivity and specificity of the probe were recorded at 93% and 87%, respectively, based on 193 samples taken from 70 patients. Founded in 2017 and headquartered in Poland, OncoScanner.com recently secured a €71.43K grant investment from EASME - EU Executive Agency for SMEs in May 2018. The company's significant achievements and focus on addressing a critical need in cancer surgery position it as a promising investment opportunity for venture capitalists seeking disruptive solutions in the healthcare sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | €71.43K | 1 | EASME - EU Executive Agency for SMEs | 01 May 2018 |
No recent news or press coverage available for OncoScanner.com.